NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Roger Stupp, Eric T. Wong, Andrew A. Kanner, David Steinberg, Herbert Engelhard, Volkmar Heidecke, Eilon D. Kirson, Sophie Taillibert, Frank Liebermann, Vladimir Dbalý, Zvi Ram, J. Lee Villano, Nikolai Rainov, Uri Weinberg, David Schiff, Lara Kunschner, Jeffrey Raizer, Jerome Honnorat, Andrew Sloan, Mark MalkinJoseph C. Landolfi, Franz Payer, Maximilian Mehdorn, Robert J. Weil, Susan C. Pannullo, Manfred Westphal, Martin Smrcka, Lawrence Chin, Herwig Kostron, Silvia Hofer, Jeffrey Bruce, Rees Cosgrove, Nina Paleologous, Yoram Palti, Philip H. Gutin

Research output: Contribution to journalArticlepeer-review

595 Citations (SciVal)

Fingerprint

Dive into the research topics of 'NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology